Effect of SGLT2 Inhibitors on Cardiovascular Outcomes and Mortality Across the Spectrum of Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Research and Clinical Practice
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 inhibitors, cardiovascular outcomes, and mortality across the spectrum of kidney disease: A systematic review and meta-analysis
Diabetes Res. Clin. Pract. 2024 Nov 18;218(xx)111933, BF Spiazzi, GF Piccoli, LF Wayerbacher, JPN Lubianca, BG Scalco, MH Scheffler, BL Fraga, V Colpani, F GerchmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.